INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract

Journal of Surgical Oncology

Volumn 111, Issue 4, 2015, Pages 414-422

  Lee, Hsiang Ying ^a   Li, Ching Chia ^a,b,c   Huang, Chun Nung ^a,c   Li, Wei Ming ^a,c,d   Yeh, Hsin Chih ^a,b,c   Ke, Hung Lung ^a,c   Yang, Kai Fu ^a   Liang, Peir In ^a   Li, Chien Feng ^e,f,g,h   Wu, Wen Jeng ^a,c,h  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d Department of Psychiatry   (Taiwan)

^e CHI MEI MEDICAL CENTER   (Taiwan)

^f NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^g SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^h KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

INHBA; Prognosis; Transcriptome; Urothelial carcinoma

Indexed keywords

CISPLATIN; INHIBIN; INHIBIN BETA A PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; INHIBIN BETA A SUBUNIT;

ADULT; AGED; ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; PRIORITY JOURNAL; TISSUE SECTION; TRANSITIONAL CELL CARCINOMA; UPREGULATION; URINARY TRACT CARCINOMA; VERY ELDERLY; CARCINOMA; GENE EXPRESSION PROFILING; GENETICS; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METABOLISM; MITOSIS; MORTALITY; PATHOLOGY; PROGNOSIS; TUMOR INVASION; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS; UROTHELIUM;

AGED; CARCINOMA; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBIN-BETA SUBUNITS; LYMPHATIC METASTASIS; MALE; MITOSIS; NEOPLASM INVASIVENESS; PROGNOSIS; RNA, MESSENGER; UP-REGULATION; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84923762972     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23836     Document Type: Article

References (28)

1. Clark PE, Agarwal N, Biagioli MC, et al.: Bladder cancer. J Natl Compr Canc Netw 2013; 11: 446-475.
2. Chen HA, Su CM, Hsieh HY, et al.: Clinical significance of survivin expression in patients with urothelial carcinoma. Dis Markers 2014; 2014: 574985.
3. Wei Y, Jiang YZ, Qian WH: Prognostic Role of NLR in Urinary Cancers: A meta-analysis. PLoS One 2014; 9: e92079.
4. Matsumoto K, Satoh T, Irie A, et al.: Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer. Urology. 2008; 72: 444-449.
5. Tsumura H, Matsumoto K, Sato Y, et al.: Abnormal expression of multiple proteins predicts cancer-specific mortality in patients with high-grade non-muscle-invasive bladder cancer treated with transurethral resection. Mol Clin Oncol. 2013; 1: 473-479.
6. Ying SY, Zhang Z, Furst B, et al.: Activins and activin receptors in cell growth. Proc Soc Exp Biol Med 1997; 214: 114-122.
7. Hofland J, van Nederveen FH, Timmerman MA, et al.: Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: Astudy based on mRNAanalysis and immunohistochemistry. Clin Endocrinol 2007; 66: 335-340.
8. Yoshinaga K, Mimori K, Yamashita K, et al.: Clinical significance of the expression of activin A in esophageal carcinoma. Int J Oncol 2003; 22: 75-80.
9. Liu SG, Li HC, Zhao BS, et al.: Expression of activin A in tissue and serum of patients with esophageal squamous cellcarcinoma and its clinical significance. Zhonghua Zhong Liu Za Zhi 2013; 35: 843-847.
10. Seder CW, Hartojo W, Lin L, et al.: Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma. Neoplasia 2009; 11: 388-396.
11. Wang Q, Wen YG, Li DP, et al.: Upregulated INHBA expression is associated with poor survival in gastric cancer. Med Oncol 2012; 29: 77-83.
12. Wildi S, Kleeff J, Maruyama H, et al.: Overexpression of activin A in stage IV colorectal cancer. Gut 2001; 49: 409-417.
13. Kleeff J, Ishiwata T, Friess H, et al.: Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer. Int J Cancer 1998; 77: 860-868.
14. Hofland J, van Weerden WM, Steenbergen J, et al.: Activin A stimulates AKR1C3 expression and growth in human prostate cancer. Endocrinology 2012; 153: 5726-5734.
15. Liang PI, Wang YH, Wu TF, et al.: IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder. J Clin Pathol 2013; 66: 573-582.
16. Singh PK, Srivastava AK, Dalela D, et al.: Expression of pdzbinding kinase/t-lak cell-originated protein kinase (pbk/topk) in human urinary bladder transitional cell carcinomas. Immunobiology 2014 Feb. pii: S0171-2985(14) 00027-8.
17. Rau KM, Chen YJ, Sun MT, et al.: Prognostic effects and regulation of activin A, Maspin, and androgen receptor in upper urinary tract urothelial carcinoma. Anticancer Res 2011; 31: 1713-1720.
18. Goodison S, Rosser CJ, Urquidi V: Bladder cancer detection and monitoring: Assessment of urine-and blood-based marker tests. Mol Diagn Ther 2013; 17: 71-84.
19. Onagbesan OM, Safi M, Decuypere E, et al.: Developmental changes in inhibin alpha and inhibin/activin betaA and betaB mRNA levels in the gonads during post-hatch prepubertal development of male and female chickens. Mol Reprod Dev 2004; 68: 319-326.
20. Chen YG, Wang Q, Lin SL, et al.: Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis. Exp Biol Med 2006; 231: 534-544.
21. Lotinun S, Pearsall RS, Horne WC, et al.: Activin receptor signaling: A potential therapeutic target for osteoporosis. Curr Mol Pharmacol 2012; 5: 195-204.
22. Kim H, Watkinson J, Varadan V, et al.: Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA. THBS2 and COL11A1. BMC Med Genomics 2010; 3: 51.
23. Seder CW, Hartojo W, Lin L, et al.: INHBA overexpression promotes cell proliferation and may be epigenetically regulated in esophageal adenocarcinoma. J Thorac Oncol 2009; 4: 455-462.
24. Hofland J, Timmerman MA, de Herder WW, et al.: Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms. Clin Endocrinol (Oxf) 2006; 65: 792-799.
25. Burdette JE, Jeruss JS, Kurley SJ, et al.: Activin A Mediates Growth Inhibition and Cell Cycle Arrest through Smads in Human Breast Cancer Cells. Cancer Res 2005; 65: 7968-7975.
26. Panopoulou E, Murphy C, Rasmussen H, et al.: Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms. Cancer Res 2005; 65: 1877-1886.
27. Jakowlew SB: Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev. 2006; 25: 435-457.
28. Thompson TB, Cook RW, Chapman SC, et al.: Beta A versus beta B: It it merely a matter of expression. Mol Cell Endocrinol 2004; 225: 9-17.